Indoor Toxicity and Fungal Inhalation Risk of Patients and Clinical Findings Eckardt Johanning, M.D., M.Sc. Manfred Gareis, DVM (BAFF-Kulmbach, FRG) Wayne.

Slides:



Advertisements
Similar presentations
Potential Health Effects of Mold Exposure in Buildings
Advertisements

GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Mycology review.
FUNGUS AND BACTERIAL RESISTANT TREATMENT FOR PAPER AND PAPERBOARD
Mold and Their Health Effects Edward J Peters, MD Austin Texas
Asthma and Inhalant Allergens
Airborne fungi infections Dr David W. Denning FRCP FRCPath Scientific Advisor to the Fungal Research Trust Clinician, Wythenshawe Hospital Head, Antifungal.
Rowan University Department of Environmental Health and Safety A Brief Overview for Building Maintenance.
Rowan University New Jersey Public Employees Occupational Safety and Health Training 1.
Markku Seuri, FIOH, MOULDY HOUSE PROBLEM Tartu
U.S. Department of Labor Occupational Safety and Health Administration Directorate of Science, Technology and Medicine Office of Science and Technology.
An Overview of Mold (There’s Fungus Among Us) Prepared by Curt Speaker PSU Environmental Health and Safety May 2003.
Sandler Occupational Medicine Associates © 2008 Current Mold Issues & Evaluation Anne M. Stumpf CSP, CIH, MS Sandler Occupational Medicine Associates,
January 25, 2005USDA Teleconference1 John L. Murray, Jr., CHMM, CSP, CIH Safety Director Occupational Health & Safety Baystate Health System Springfield.
PRESENTS Mold What you should know.. What is mold? Mold is considered a sub-group of the Fungi Kingdom Mold are asexual fungi Present on clothing, carpet,
WHAT DOES MOLD MEAN? by J. H. Haines New York State Museum Biological Survey Albany, NY.
Asthma and Allergy  Atopy v Allergy  Asthma Aeroallergens – indoor & outdoor Aeroallergens – indoor & outdoor  Occupational allergens.
VALIDATION OF THE QUESTIONNAIRE SURVEY RESULTS IN IDENTIFICATION OF ATOPY IN SCHOOL CHILDREN INSTITUTE OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH.
Journal Club Alcohol and Health: Current Evidence November-December 2005.
Measurements of biological contaminants - WP3.3 SINPHONIE Project kick-off meeting November, REC Conference Center, Szentendre Hungary Martin Täubel,
Risk Factors for Developing Asthma  Genetic characteristics  Occupational exposures  Environmental exposures.
1 Occupational asthma Provocation tests and lung function measurements in diagnostics Treatment and follow up Ritva Piipari, TTL.
Immunology of Asthma Immunology Unit Department of Pathology King Saud University.
Immunology of Asthma Dr. Hend Alotaibi Assistant Professor & Consultant College of Medicine, King Saud University Dermatology Department /KKUH
INDOOR AIR QUALITY: EFFECTS ON HUMAN HEALTH Kenneth H. Dangman, PhD, MD, MPH, Eileen Storey, MD, MPH, and Michael J. Hodgson, MD, MPH from the Division.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
Occupational Health Introduction
Building Related Illness Fred Fung, M.D., M.S. (Tox) Toxicology Consultant, UC San Diego Occupational Medicine, UC Irvine Sharp Rees-Stealy Medical Group.
Environmental Hazards in Your School Explorer’s Guild Vicki Hanrahan Ainslie November 2004.
Diagnostic Strategies for Occupational Asthma Louis-Philippe Boulet, MD, FRCPC Institut de cardiologie et de pneumologie de l’Université Laval, Hôpital.
Case Histories John W. Martyny, Ph.D., CIH Tri-County Health Department.
Biologically Derived Airborne Contaminants: Bioaerosols and TLVs ® Kenneth F. Martinez, MSEE, CIH Chair, ACGIH ® Bioaerosols Committee NIOSH.
ALLERGOLOGY The branch of medical science that studies the causes and treatment of allergies.
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Lecture 6: Reliability and validity of scales (cont) 1. In relation to scales, define the following terms: - Content validity - Criterion validity (concurrent.
Washington State DOH1 MOLDS WHY DO WE CARE?. Washington State DOH2 MOLDS F Health effects F Common molds F Testing for molds F Clean-up of moldy environments.
1. 2 Indoor Air Quality (IAQ) (Awareness)  Americans spend up to 90% of their time indoors  People may be exposed to indoor air pollutants for long.
Occupational asthma What is an occupational asthma?
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Introduction Also known as “sick building syndrome”, Stachybotrys chartarum is becoming a much publicized problem in the United States after large outbreaks.
Identification of Hazardous Airborne Organisms Beth Kerr Brita Roy Advisors: Dr. Todd D. Giorgio and Dr. Paul H. King.
Effectiveness of Spore Trap Only Sampling Richard Billups Laboratory Director Air Allergen & Mold Testing Atlanta, Ga.
Asthma A Presentation on Asthma Management and Prevention.
CLINICAL EFFICACY TESTING for NASAL DRUGS Mary M. Fanning, M.D., Ph.D. Associate Director for Medical Affairs Office of Generic Drugs, FDA June 4, 1999.
Estimation of the risk factors in chronic respiratory diseases of the children Cebanu Sergiu State Medical and Pharmaceutical University “Nicolae Testemitanu”
Sampling Methods. Sampling Purpose –Detect and quantify –Identify sources/amplification –Assess potential virulence –Assess effectiveness of controls.
Potential Health Effects 1. Objective: To present information about health hazard concerns associated with mold assessment and remediation projects. 2.
IgM ELISA CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY Jan. 1998, p. 7–10 Vol. 5, No. 1 Copyright © 1998, American Society for Microbiology.
Adverse Health Effects of Indoor Mold Exposure Overview of the 2011 ACOEM Statement Anthony Burton, MD MPH General Motors-Romulus.
1 Mold and Mildew Awareness Indoor Air Quality. 2 Toxic Mold A few years ago, few people had ever heard of "Toxic Mold“ Stachybotrys  $100 million lawsuits.
AWARENESS AND GUIDANCE OF DERMATITIS RISKS IN HEALTHCARE WORKERS.
Dr Mazen Qusaibaty MD, DIS / Head Pulmonary and Internist Department Ibnalnafisse Hospital Ministry of Syrian health – Dr Mazen.
Mold : Health Effects Kenneth Hellevang, Ph.D., P.E. North Dakota State University Fargo, ND.
Types of Molds and its Effect to People’s Health.
Fungal diseases in the UK
Johnathan Grant D.O. FACOI
Mold What you should know.
Why buildings are key to achieve a better health in the EU?
Relationship between CMV & PU disease
Multiple Organ Dysfunction Syndrome (MODS)
Fungal Assessment by culture and RT-PCR assay in a Waste Sorting Plant
Lessons for inhabitants living in damp tropical buildings
by J. H. Haines New York State Museum Biological Survey Albany, NY
Mold in the Workplace Investigation Wisdom Consultants.
Dr Amy Stebbings The Chest and Internal Medicine Clinic, Singapore
Mold in the Workplace Investigation Wisdom Consultants.
Prevalence of Asthma, Rhinitis and Eczema in Saudi Arabia * Physicians’ diagnosed Asthma + highly suspected asthma * 1986: n=2123, 1995: n=1008, 2001:n=1014.
Herpesviruses and the microbiome
Exposure to cow’s milk during the first 3 months of life is associated with increased levels of IgG subclass antibodies to β-lactoglobulin to 8 years 
Table 1. Diagnostic methods for systemic fungal infection (n=70)
Presentation transcript:

Indoor Toxicity and Fungal Inhalation Risk of Patients and Clinical Findings Eckardt Johanning, M.D., M.Sc. Manfred Gareis, DVM (BAFF-Kulmbach, FRG) Wayne Gordon (MSMC, New York, USA) Occupational and Environmental Life Science Fungal Research Group Foundation, Albany, N.Y.

Fungal Research Group Foundation 2008

Fungal Exposure: Various agents and disease outcomes Agents: Allergens Ergosterol (1-3)-ß-D-glucan Mycotoxins microbial volatile organic compounds (MVOCs) ??? Allergy + Non-allergic Dermatitis, Urticaria Rhinitis, Sinusitis Asthma Extrinsic allergic alveolitis “humidifier fever” Organic dust toxic syndrome Toxic – irritant effects Fungal Research Group Foundation 2008

Diagnostic problems Exposure Multiple Mixture - dose Non-specific symptoms Multiple disease endpoints Fungal Research Group Foundation 2008

-Mycotoxicosis -Hypersensitivity pneumonitis -Bronchitis -Allergic diseases -Dermatitis; air way infections - Irritative and non-specific symptoms rare frequent irreversible irreversible reversible Health effects of fungi Fungal Research Group Foundation 2008

Patients evaluated in occupational and environmental health clinic from December 1999 to February, 2005 *Adult patients (Patients ≥ 18 years at time of visit, exposure duration ~ 2y) *Advanced environmental testing (including airborne cytotoxicity study MTT) *Completed self-administered health questionnaire. Compared to adult clinic patients (controls) without self- reported exposure to dampness/mold at home or at work. Fungal Research Group FRGF Database

Fungal Research Group FRGF Demographics AgeGender - Smoker *** = p < 0.001

Symptom complex Patient: n = 95; Control: n = 26 Fungal Research Group Foundation 2008

Fungal Research Group FRG, Inc. Pulmonary function test abnormalities

Patient’s IgG Antibody response and comparison with environmental sampling identification Fungal Research Group FRGF

Patient’s IgG Antibody response and comparison with environmental sampling identification Fungal Research Group FRGF

Patient’s IgE Antibody response and comparison with environmental sampling identification Fungal Research Group FRGF

IgE Mold Specific Antibodies & Environmental Exposure Fungal Research Group FRGF.

IgA Mold Specific Antibodies & Stachybotrys chartarum exposure Fungal Research Group FRGF

Serological Marker Sensitivity, Specificity, positive and negative predictive value Fungal Research Group Foundation 2008

Airborne fungal toxicity assessment Fungal Research Group FRGF METHODS Indoor environments of 55 patients (1999 and 2005) with verified moisture related building damage and indoor fungal growth were studied. In total, 161 high-volume air samples were analyzed for trichothecene (Roridin A) content by the ELISA method and fungi in this comparison.

Air sampling (24 h) Mycology with special attention to Stachybotrys ch. Inhalation Exposure - Logistics and Methodology CaseClinical data Bulk samples 7 Mycotoxin analysesToxicity Mycology Mycotoxins Toxicity HPLC-DAD GC-MS EIA Cytotoxicity screening of crude extracts (MTT-test) paper in preparation Fungal Research Group Foundation 2008

RESULTS 69.6% of the samples analyzed for RoA showed levels >2 ng/g, 8.7 % were > 50 ng/g Fungal Research Group Foundation 2008

Airborne Cyto-Toxicity Results: Samples Fungal Research Group Foundation 2008

Airborne Cytotoxicity & Viable Fungi RoA Elisa (ng/g) Spearman’s Viable fungi (% yes, (n))level< 22 < 55 < 1010 < 50=> 50 Approx. TApprox. p Acremonium sp. (+)4.0 (1) 0.0 (0) (2) 16.0 (4) (2)4.0 (1)8.0 (2)4.0 (1) (0)4.0 (1) 0.0 (0) Alternaria sp. (+)7.7 (1)no data7.7 (1)0.0 (0) (2)no data15.4 (2)7.7 (1)15.4 (2) (2)no data0.0 (0) 15.4 (2) Aspergillus sp. (+)2.0 (2) 0.0 (0) (13)15.8 (16)16.8 (17)4.0 (4) (9)5.9 (6)2.0 (2)4.0 (4) (6)1.0 (1)5.0 (5)2.0 (2) Chaetomium sp. (+)5.9 (1)0.0 (0)0.0 (0)`0.0 (0) (0)5.9 (1)17.6 (3)5.9 (1)23.5 (4) (2)0.0 (0)5.9 (1)0.0 (0) (2)0.0 (0) Cladosporium sp. (+)1.4 (1) 4.1 (3)1.4 (1)0.0 (0) (17)18.9 (14)17.6 (13)6.8 (5)2.7 (2) (5)2.7 (2)0.0 (0)5.4 (4) (0) 2.7 (2) Paecilomyces sp. (+)0.0 (0)3.6 (1)10.7 (3)3.6 (1)0.0 (0) (0)10.7 (3) 7.1 (2)14.3 (4) (1)0.0 (0)3.6 (1)0.0 (0) Penicillium sp (12)14.4 (16)10.8 (12)9.0 (10)4.5 (5) (16)4.5 (5)5.4 (6)4.5 (5)2.7 (3) (10)2.7 (3) 3.6 (4) Fungal Research Group Foundation 2008

Airborne Cytotoxicity & Viable Fungi Stachybotry s sp. (+)0.0 (0) 7.1 (1) 0.0 (0) (3)0.0 (0)7.1 (1)14.3 (2)0.0 (0) (0) 21.4 (3) (0)7.1 (1)0.0 (0) 14.3 (2) Trichoderma sp. (+)11.1 (2)0.0 (0)5.6 (1) no data (4)11.1 (2) no data (1)11.1 (2)0.0 (0) no data (0) 5.6 (1)0.0 (0)no data Viable fungi (% yes, (n))level< 22 < 55 < 1010 < 50=> 50 Approx. TApprox. p RoA Elisa (ng/g) Spearman’s Fungal Research Group Foundation 2008

Cytotoxicity Testing of Filter Papers from 24 h Air Sampling n=7 n=14 Inhalation Exposition - Results n cases Stachybotrys chartarum Macrocyclic Trichothecenes toxic samples III Fungal Research Group Foundation 2008

Fungal toxicity and neurocognitive dysfunction (W. Gordon, PhD et al) Fungal Research Group FRGF 22 neurocognitive cases selected that included indoor air toxicity assessments22 neurocognitive cases selected that included indoor air toxicity assessments

Brain Injury Screening Questionnaire (BISQ) Results: Gorden et.al., Applied Neuropsychology 2004, Vol. 11, No.2, Fungal Research Group FRGF Patients with (toxigenic) indoor mold exposure history and traumatic brain injury report similar symptoms and problems

Neurocognitive Testing Results, WMS III, Airborne Toxicity Findings Fungal Research Group FRGF Of 22 neurocognitive cases selected that included indoor air toxicity assessments

Neurocognitive Testing Results, WMS III, Airborne Toxicity Findings Fungal Research Group FRGF Of 22 neurocognitive cases selected that included indoor air toxicity assessments

Neurocognitive Testing Results, WMS III, Toxicity, % Reduced functioning (  16 th percentile) Fungal Research Group FRGF * = p < 0.05 Of 22 neurocognitive cases selected that included indoor air toxicity assessments

Neurocognitive Testing Results, WMS III, Toxicity, % Reduced functioning (  16 th percentile) Fungal Research Group FRGF 22 neurocognitive cases selected that included indoor air toxicity assessments22 neurocognitive cases selected that included indoor air toxicity assessments

Reviews and committee papers – who are the reviewer and what are their motives? ACOEM – “Mold - Evidence Paper” – American College of Occupational and Environmental Medicine (10/2002) –Authors: Hardin, Kelman, Saxon –See also: Manhattan Institute (same content) (7/03) IOM - Damp Indoor Spaces and Health –Institute of Medicine (2004) Kuopio Finland Toxic Mold Meeting (7/2004) –ISIAQ Norddamp (Bornehag et al, 2004) Fungal Research Group Foundation 2008

Critique of “evidence Papers” Fungal Research Group Foundation 2008 The motives and intentions of the authors have been examined and questioned: –“A Critique of the ACOEM Statement on Mold: Undisclosed Conflicts of Interest in the Creation of an “Evidence-based” Statement” By JAMES CRANER in INT J OCCUP ENVIRON HEALTH 2008;14:283–298 –“Court of Opinion: Amid Suits Over Mold. Experts Wear Two Hats; Authors of Science Paper Often Cited by Defense Also Help in Litigation” By David Armstrong. Wall Street Journal. (Eastern edition). New York, N.Y.: Jan 9, –“Position paper on molds by AAAAI is seriously flawed”. A Critique of the AAAAI Statement on Mold: The medical effects of mold exposure. by Bush RK, Portnoy JM, Saxon A, Terr AI, Wood RA. J Allergy Clin Immunol 2006;117: Letters to editor of journal by different authors see: J ALLERGY CLIN IMMUNOL VOLUME 118, NUMBER 3

APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Nov. 2005, p. 7376–7388 Vol. 71, No. 11 Fungal Research Group Foundation 2008

Conclusions Patient IgE and IgG show limited correlation with specific environmental findings (low sensitivity, good specificity) Patient show (also) non IgE- or IGG- mediated or associated exposure effects New onset of symptoms and abnormalities in non-sensitized patients (new onset Dx) Fungal Research Group Foundation 2008

Conclusions Cognitive impairment symptoms similar to patients with traumatic brain injury (TBI) Airborne (fungal) toxicity appear to be correlated with some neurocognitive dysfunction Improved, specific exposure data necessary to improve environmental/occupational diagnosis Mycotoxin body burden indicator needed to validate study findings Fungal Research Group Foundation 2008

Conclusions Airborne Satratoxins (macrocyclic trichothecenes) Detection of mycotoxins in air samples not or weakly correlated with fungal spores S. chartarum not necessarily correlated with the presence of satratoxins Other cytotoxic compounds could be detected by use of the bioassay Methods appears to be reliable to differentiate between cytotoxic and non-cytotoxic filter papers, i.e. toxic and non-toxic environments Fungal Research Group Foundation 2008

“Wissen ist nicht genug – wir müssen handeln” “Knowing is not enough; we must apply.” - J. W. Goethe Child with asthma in Spanish Harlem, N.Y. … Johanning et al; EHP 1999;107 (3) Fungal Research Group Foundation 2008